Euro Medical Oncology and Radiology Congress will provide a format for identifying concerns, providing advancements and expert guidance in treatment for cancer, from a new diagnosis to recurrence and end of life. It aims to promote science and cooperation of all groups with activities in the area of medical and surgical oncology.
Organ Specific Oncologists
General and Emergency Physicians
Academicians and Researchers
Early Bird Registration: Dec 11, 2020
Abstract Submission Deadline: Jan 18, 2021
Participation Confirmation Deadline: Jan 23, 2021
Euro Medical Oncology and Radiology Congress
Euro Medical Oncology and Radiology Advisory Committee has designed this multidisciplinary program to offer participants a unique opportunity to learn from leading experts in the field of Oncology. This congress will cover the management and treatment of patients using the emerging and expanding approach through facilitating the exchange of ideas.
MedOncoRad Congress 2021, will offer opportunity for Oncologists, allied healthcare providers, researchers and clinical physicians to discuss the latest developments in cancers and translate them into new scientific direction involving basic biology and pathways that eventually lead to new individualized therapies for cancer patients to improve clinical care. Particular emphasis is put on optimal treatment strategies, clinical oncology, womens healthcare and public health aspects of diagnosis, prevention and management throughout Europe and other regions.
The unparalleled content will focus on new diagnostic and late effects after treatment that incorporate immunotherapy associated toxicities, genomics, and state-of-the-art technologies for cancers. Surgeons and Oncologists will learn about novel approaches and how to employ them in their practices through a variety of interactive and informative presentations including peer-reviewed abstracts, interactive networking with internationally-recognized experts.
Father of Medical Oncology: Byrl James "B.J." Kennedy (1921 - 2003)
Father of Modern Cancer Immunology: Lloyd John Old (1933 - 2011)
Noble Prize Laureates:
William G. Kaelin, Jr., MD, Sir Peter J. Ratcliffe, MD, and Gregg L. Semenza | 2019 Nobel Prize | Physiology or Medicine | Discovered the molecular “switch” that controls how cells respond to changing oxygen levels
James Allison and Tasuku Honjo | 2018 Nobel Prize | Physiology or Medicine | Pioneering work on cancer immunotherapy
Ralph Steinman | 2011 Nobel Prize | Physiology or Medicine | Discovered dendritic cell, which led to the first therapeutic vaccine for prostate cancer, Provenge
Mario R. Capecchi and Oliver Smithies | 2007 Nobel Prize | Physiology or Medicine | Identification of genes that are targets of cancer therapies
Edward B. Lewis | 1995 Nobel Prize | Physiology or Medicine | Certain patterns in development apply to human cancers